HF
RYTM icon

HRT Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

HRT Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-54,534
Closed -$2.51M – 2986
2023
Q4 		$2.51M Buy
54,534
+3,982
+8% +$126K 0.02% 547
2023
Q3 		$1.16M Buy
+50,552
New +$1.13M 0.01% 889
2023
Q2 		– Sell
-218,445
Closed -$3.9M – 3161
2023
Q1 		$3.9M Buy
+218,445
New +$5.49M 0.05% 324
2022
Q2 		– Sell
-49,198
Closed -$566K – 3623
2022
Q1 		$566K Buy
49,198
+23,280
+90% +$204K ﹤0.01% 1555
2021
Q4 		$258K Buy
+25,918
New +$291K ﹤0.01% 2360

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

HRT Financial's RYTM Position: Q1 2024 in Review

HRT Financial sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2024, closing a stake of 54,534 shares — an estimated $2.51M sold.

HRT Financial first reported a position in RYTM in Q4 2021 and held it in 5 quarters. The position peaked at $3.9M in Q1 2023. 167 funds tracked by Wall St. Rank hold RYTM as of Q1 2024.

  • HRT Financial reported no remaining Rhythm Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 54,534 Rhythm Pharmaceuticals shares in Q1 2024, an estimated $2.51M.
  • HRT Financial first reported a position in Rhythm Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • HRT Financial's Rhythm Pharmaceuticals position peaked at $3.9M in Q1 2023.
  • 167 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.